MOUNTAIN VIEW, Calif., and COLUMBIA, MARYLAND – March 6, 2018 – Samsung Electronics America, Inc. and WellDoc®, a leading digital therapeutic company, announced today that Samsung Health users now have access to a new consumer version of WellDoc’s digital platform known as the Diabetes Wellness Program (DWP). The DWP, which is integrated within the Samsung Health service, is a 12-week health and wellness program developed in collaboration with key partners, including the American Association of Diabetes Educators (AADE). It is designed to help adults with type 2 diabetes achieve a healthy lifestyle and to help manage their condition.
Samsung Health is a personal health service designed to empower individuals to manage their health and fitness. It features a comprehensive platform that displays user activity trends and provides health insights, telehealth services and helpful feedback to connect users, friends and experts all while promoting healthier lifestyles. Available through the Samsung Health service*, the DWP is powered by WellDoc’s platform that is used in its BlueStar® product. This consumer version provides personalized information for users, such as interactive quizzes and videos, and the ability to conveniently monitor food intake, exercise, sleep, medication, and blood glucose readings for better diabetes self-management. Users benefit from helpful features including instant feedback from blood glucose entries and medication reminders, as well as motivation through weekly challenges and rewards for achieving goals.
“The integration of key, consumer-facing aspects of our proprietary BlueStar® platform within the Samsung Health service is a very exciting next step as our partnership with Samsung continues to advance,” said WellDoc President and CEO Kevin McRaith. “The Diabetes Wellness Program allows individuals in the United States with Samsung Health on the latest Samsung Galaxy mobile phone the opportunity to become educated and empowered to more effectively manage their health and wellness and experience a better quality of life. It’s an invaluable option for the mass population to help manage their health and wellness, and we look forward to making it available outside of the U.S. in the near future.”
Individuals living with type 2 diabetes must pay close attention to their care each day, taking daily medications and/or administering insulin injections, measuring blood glucose levels, and adhering to a strict diet and lifestyle plan.
“Partnering with WellDoc in developing a comprehensive diabetes health and wellness program for Samsung Health users was a natural fit, and an important milestone in our overall chronic disease management strategy,” said Nana Murugesan, Vice President & General Manager, Services & New Business at Samsung Electronics America. “With WellDoc’s unique focus on clinical outcomes and user engagement in the digital health space, the Diabetes Wellness Program will give Samsung Health users an opportunity to effectively manage their chronic condition on the comprehensive platform.”
To sign-up, users can navigate to the Samsung Health app, select “Programs” within the three dots menu in the upper right, and the Diabetes Wellness Program is found under the “Disease Management” section.
* The DWP is a wellness tool and not a medical device. It is not intended to prevent, treat or diagnose any disease or condition. The DWP does not provide medical advice and is not intended to replace the judgment of a consumer’s healthcare professional. The Diabetes Wellness Program is available through the Samsung Health app version 5.14, available for download with select carriers on Samsung Galaxy S6 and above smartphones in the U.S.
WellDoc® is a leading digital health company revolutionizing chronic disease management to help transform lives. Our groundbreaking technology is guiding individuals through the complicated journey of living with chronic diseases, with a goal of improving their health and helping them to be more balanced. We are the first digital health company based on a life science business model with a foundation that is built on randomized clinical trials that demonstrate significant clinical outcomes. We have mastered diabetes management by taking an aggressive and innovative approach that utilizes sophisticated logic and precise algorithms, and integrates the most advanced mobile technology, behavioral insight, and diabetes education for those living with type 2 diabetes.
Our FDA-cleared, proven digital therapeutic, BlueStar®, provides real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personal. Our clinical evidence shows a 1.7 to 2.0-point mean A1C reduction for adults living with type 2 diabetes who used BlueStar®. In November 2017, the IQVIA Institute for Human Data Science (formerly Quintiles/IMS) named BlueStar the “top app” in clinical diabetes treatment. For more information, visit www.welldoc.com.
BerlinRosen for Samsung Electronics America